專業從事
生命科學儀器技術服務13382235337
ELICITYL總部位于法國格勒諾布爾，是一家致力于復雜糖類工程和生產的生物技術公司。該公司的任務是針對植物健康，藥學，營養保健品和化妝品為生物應用提供寡糖和多糖。
| 品牌 | 貨號 | 品名 | 規格 | 價格 |
| elicityl-oligotech | GLY090-NAc-sp3-Bt | 3'-Sialyllactose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY092-NAc-sp3-Bt | GT3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY091-NAc-sp3-Bt | GD3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY093-NAc-sp3-Bt | GM2 Ganglioside oligosaccharide - Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY098-NAc-sp3-Bt | GD1a Ganglioside oligosaccharide - Biotin | 5mg | 詢價 |
| elicityl-oligotech | GLY096-NAc-sp3-Bt | GM1a Ganglioside oligosaccharide - Biotin | 5mg | 詢價 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 100mg | 374 |
| elicityl-oligotech | ALG102 | Alginate polysaccharides (from Ascophyllum nodosum) | 100mg | 374 |
| elicityl-oligotech | GLU312-99% | Maltose DP2 (>99% HPLC) | 100mg | 561 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 500mg | 654.5 |
| elicityl-oligotech | ALG103 | Alginate polysaccharides (from Chorda filum) | 100mg | 654.5 |
| elicityl-oligotech | ALG104 | Alginate polysaccharides (from Durvillaea antarctica) | 100mg | 654.5 |
| elicityl-oligotech | ALG100 | Alginate polysaccharides (from Laminaria japonica) | 100mg | 841.5 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 1000mg | 841.5 |
| elicityl-oligotech | ALG102 | Alginate polysaccharides (from Ascophyllum nodosum) | 1000mg | 841.5 |
| elicityl-oligotech | GLU200 | Xanthan gum polysaccharide | 100mg | 841.5 |
| elicityl-oligotech | GLU420 | Chitosan polysaccharide | 1000mg | 935 |
| elicityl-oligotech | ARB106 | Arabinan polysaccharides from sugar Beet | 100mg | 1122 |
| elicityl-oligotech | GLY142 | N-acetylmannosamine | 1000mg | 1122 |
| elicityl-oligotech | GLY143-99% | L-Fucose | 1000mg | 1122 |
| elicityl-oligotech | ALG103 | Alginate polysaccharides (from Chorda filum) | 1000mg | 1309 |
| elicityl-oligotech | ALG104 | Alginate polysaccharides (from Durvillaea antarctica) | 1000mg | 1309 |
| elicityl-oligotech | FRU110 | Fructo-oligosaccharides mixture from Jerusalem artichoke (Cut-off < 10kDa) | 100mg | 1309 |
| elicityl-oligotech | FUC400 | Fucoidan polysaccharide from Ascophyllum nodosum | 100mg | 1402.5 |
| elicityl-oligotech | FUC500 | Fucoidan polysaccharide from Durvillea antarctica | 100mg | 1402.5 |
| elicityl-oligotech | GLY070-70% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>70% NMR) | 5mg | 1402.5 |
| elicityl-oligotech | GLY141 | N-acetylgalactosamine | 1000mg | 1402.5 |
| elicityl-oligotech | GLY140-80% | Sialic acid (N-acetylneuraminic acid) (>80% NMR) | 1000mg | 1589.5 |
| elicityl-oligotech | GAL100 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Native grade | 1000mg | 1683 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 25mg | 1776.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 25mg | 1776.5 |
| elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 5mg | 1776.5 |
| elicityl-oligotech | GLY140-90% | Sialic acid (N-acetylneuraminic acid) (>90% NMR) | 1000mg | 1776.5 |
| elicityl-oligotech | GLY090-90% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 100mg | 1963.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 25mg | 1870 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 50mg | 1870 |
| elicityl-oligotech | GLU700 | Scleroglucan polysaccharide | 5000mg | 1870 |
| elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 10mg | 2057 |
| elicityl-oligotech | ALG500 | Mannuronate oligosaccharides Average DP20 (sodium salt) | 25mg | 2057 |
| elicityl-oligotech | GLU312-95% | Maltose DP2 (>95% HPLC) | 500mg | 1963.5 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 25mg | 1963.5 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 50mg | 1963.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 50mg | 1963.5 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 25mg | 1963.5 |
| elicityl-oligotech | ALG600 | Manuronic Block OLS. DP30-DP50 M/G ratio>4 | 10mg | 2057 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 25mg | 2057 |
| elicityl-oligotech | FRU101-90% | 1-Kestose (DP3) / GF2 (>90% NMR) | 10mg | 2057 |
| elicityl-oligotech | FRU101-95% | 1-Kestose (DP3) / GF2 (>95% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | FRU102-90% | Nystose (DP4) / GF3 (>90% NMR) | 10mg | 2057 |
| elicityl-oligotech | FRU102-95% | Nystose (DP4) / GF3 (>95% NMR) | 10mg | 2057 |
| elicityl-oligotech | FRU102-98% | Nystose (DP4) / GF3 (>98% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 5mg | 2057 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 5mg | 2057 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 5mg | 2057 |
| elicityl-oligotech | FUC310 | Fucoidan oligosaccharides (Cut-off < 10kDa) from Chorda filum | 10mg | 2057 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 10mg | 2057 |
| elicityl-oligotech | GAT300 | Rhamnogalacturonan polysaccharide from gombo/okra (sodium salt)) | 10mg | 2057 |
| elicityl-oligotech | GLU1111 | Reduced XFG xyloglucan oligosaccharide (DP7) XFGol | 10mg | 2057 |
| elicityl-oligotech | GLU1161 | Reduced XLFG xyloglucan oligosaccharide (DP10) XLFGol | 10mg | 2057 |
| elicityl-oligotech | GLU300-90% | Cellobiose (>90% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | GLU301-90% | Cellotriose (>90% HPAEC-PAD) | 10mg | 2057 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 25mg | 2057 |
| elicityl-oligotech | GLU316-90% | Maltohexaose DP6 (>90% HPLC) | 100mg | 2057 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 50mg | 2057 |
| elicityl-oligotech | GLU422 | Chitosan oligosaccharide - average DP60 | 10mg | 2057 |
| elicityl-oligotech | GLU423 | Chitosan oligosaccharide - average DP40 | 10mg | 2057 |
| elicityl-oligotech | GLU424 | Chitosan oligosaccharide - average DP24 | 10mg | 2057 |
| elicityl-oligotech | GLU425 | Chitosan oligosaccharide - average DP12 | 10mg | 2057 |
| elicityl-oligotech | GLU426 | Chitosan oligosaccharide - average DP6 | 10mg | 2057 |
| elicityl-oligotech | GLU427 | Chitosan oligosaccharide - average DP15-20 | 10mg | 2057 |
| elicityl-oligotech | GLU511 | Curdlan polysaccharide β-(1-3) linked linear glucan prepared by bacterial fermentation | 100mg | 2057 |
| elicityl-oligotech | GLU601 | Isolichenan polysaccharide | 100mg | 2057 |
| elicityl-oligotech | GLU602 | Lichenan & Isolichenan polysaccharide Native grade | 1000mg | 2057 |
| elicityl-oligotech | GLU800 | Lentinan polysaccharide | 10mg | 2057 |
| elicityl-oligotech | GLY008-80% | N-Acetyl-D-Lactosamine (LacNAc) (>80% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY008-90% | N-Acetyl-D-Lactosamine (LacNAc) (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 5mg | 2057 |
| elicityl-oligotech | GLY030-80% | Blood group H antigen disaccharide (>80% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY030-90% | Blood group H antigen disaccharide (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY031-2-50% | Blood group H antigen triaose type 2 (>50% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY031-2-95% | Blood group H antigen triaose type 2 (>95% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY153-90% | α1-3 galactobiose / Galα1-3Gal (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | GLY153-NPR | Galα1-3Gal-N-Acetyl-Propargyl | 1mg | 2057 |
| elicityl-oligotech | GLY221-AP | Galactose-β-Aminopropyl | 25mg | 2057 |
| elicityl-oligotech | MAN200 | Galactomannan polysaccharides from Guar | 500mg | 2057 |
| elicityl-oligotech | MAN201 | Galactomannan polysaccharides from Carob (locust bean gum) | 1000mg | 2057 |
| elicityl-oligotech | MAN202 | Galactomannan polysaccharide from Fenugreek | 100mg | 2057 |
| elicityl-oligotech | MAN600 | Glucomannan polysaccharide from Konjac | 1000mg | 2057 |
| elicityl-oligotech | MAN610 | Glucomannan oligosaccharides (cut-off < 10kDA) | 10mg | 2057 |
| elicityl-oligotech | ULV010 | Ulvan oligosaccharides (Cut-off < 10kDa) from Ulva sp. | 10mg | 2057 |
| elicityl-oligotech | ULV011 | Ulvan oligosaccharides (Cut-off < 10kDa) from Enteromorpha sp. | 10mg | 2057 |
| elicityl-oligotech | ULV100 | Ulvan polysaccharides from Ulva sp. Native grade | 100mg | 2057 |
| elicityl-oligotech | XYL110 | Xylan oligosaccharides XOs (Cut-off < 10kDA) from Palmaria p. | 10mg | 2057 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 100mg | 2057 |
| elicityl-oligotech | GLY031-2-90% | Blood group H antigen triaose type 2 (>90% NMR) | 5mg | 2057 |
| elicityl-oligotech | ALG601 | Manuronic Block OLS. DP20-DP35 M/G ratio>4 | 10mg | 2150.5 |
| elicityl-oligotech | ALG610 | Guluronate Block OLS. DP25-DP45 | 10mg | 2150.5 |
| elicityl-oligotech | GAT110 | Galacturonan oligosaccharides blocks (OGAs) | 100mg | 2150.5 |
| elicityl-oligotech | GLU312-98% | Maltose DP2 (>98% HPLC) | 500mg | 2150.5 |
| elicityl-oligotech | GLU313-95% | Maltotriose DP3 (>95% HPLC) | 100mg | 2150.5 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 50mg | 2150.5 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 25mg | 2150.5 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 50mg | 2150.5 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 50mg | 2150.5 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 25mg | 2150.5 |
| elicityl-oligotech | GLY031-3-85% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>85% NMR) | 5mg | 2150.5 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 100mg | 2337.5 |
| elicityl-oligotech | GAT200 | Apiogalacturonan polysaccharide (sodium salt) | 10mg | 2244 |
| elicityl-oligotech | GLU1141 | Reduced XLLG oligosaccharide (XLLGol) | 10mg | 2244 |
| elicityl-oligotech | GLU300-95% | Cellobiose (>95% HPAEC-PAD) | 10mg | 2244 |
| elicityl-oligotech | GLU301-95% | Cellotriose (>95% HPAEC-PAD) | 10mg | 2244 |
| elicityl-oligotech | GLU302-90% | Cellotetraose (>90% HPAEC-PAD) | 10mg | 2244 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 100mg | 2244 |
| elicityl-oligotech | GLU411 | Colloidal Chitin polysaccharide | 100mg | 2244 |
| elicityl-oligotech | GLY009-90% | Lacto-N-Biose (>90% HPLC) | 5mg | 2244 |
| elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | GLY033-1-90% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | HGL200 | Glucurono-XyloMannan polysaccharide from Tremella fuciformis | 10mg | 2244 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 5mg | 2244 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 5mg | 2337.5 |
| elicityl-oligotech | GLU312-99% | Maltose DP2 (>99% HPLC) | 500mg | 2337.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 50mg | 2337.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 50mg | 2337.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 10mg | 2337.5 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 1mg | 2337.5 |
| elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 5mg | 2337.5 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 100mg | 2337.5 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 100mg | 2431 |
| elicityl-oligotech | GAT101 | Galacturonan polysaccharides HM from apple (sodium salt) | 1000mg | 2431 |
| elicityl-oligotech | GAT103 | Galacturonan polysaccharides HM from citrus (sodium salt) | 1000mg | 2431 |
| elicityl-oligotech | GLU301-98% | Cellotriose (>98% HPAEC-PAD) | 10mg | 2431 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 100mg | 2431 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 1mg | 2431 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 10mg | 2431 |
| elicityl-oligotech | GLU900 | Pustulan polysaccharide | 100mg | 2431 |
| elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 5mg | 2431 |
| elicityl-oligotech | GLU302-95% | Cellotetraose (>95% HPAEC-PAD) | 10mg | 2524.5 |
| elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 5mg | 2524.5 |
| elicityl-oligotech | GLY033-1-95% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>95% NMR) | 5mg | 2524.5 |
| elicityl-oligotech | GLU313-98% | Maltotriose DP3 (>98% HPLC) | 100mg | 2618 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 50mg | 2618 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 50mg | 2618 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 10mg | 2618 |
| elicityl-oligotech | GLY070-95% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>95% NMR) | 5mg | 2618 |
| elicityl-oligotech | ALG310 | Guluronate oligosaccharides average DP10 (sodium salt) | 10mg | 2805 |
| elicityl-oligotech | ALG510 | Mannuronate oligosaccharides Average DP10 (sodium salt) | 10mg | 2805 |
| elicityl-oligotech | FRU101-90% | 1-Kestose (DP3) / GF2 (>90% NMR) | 25mg | 2711.5 |
| elicityl-oligotech | GAL110 | Sulfated Arabinogalactan oligosaccharides (cut-off < 10kDA) | 10mg | 2711.5 |
| elicityl-oligotech | GAT112 | Galacturonan oligosaccharides Mixture DP7/DP8 | 10mg | 2711.5 |
| elicityl-oligotech | GAT11x | Galacturonan oligosaccharides Mixture DP5/DP7 | 10mg | 2711.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 100mg | 2711.5 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 50mg | 2711.5 |
| elicityl-oligotech | GLU432-90% | Chitin oligosaccharides DP2 /chitinbiose (>90% RMN) | 10mg | 2711.5 |
| elicityl-oligotech | GLU433-90% | Chitin oligosaccharides DP3 / chitintriose (>90% RMN) | 10mg | 2711.5 |
| elicityl-oligotech | GLU600 | Lichenan polysaccharide | 1000mg | 2711.5 |
| elicityl-oligotech | GLY120-90% | Globotriaose (Gb3) / Pk antigen (>90% HPLC) | 5mg | 2711.5 |
| elicityl-oligotech | MAN219 | Galactomannan oligosaccharides DP9 from Carob | 10mg | 2711.5 |
| elicityl-oligotech | MAN400 | α-galactosyl Mannobiose & Mannotriose | 10mg | 2711.5 |
| elicityl-oligotech | MAN802 | Mannan polysaccharide from Yeast | 10mg | 2711.5 |
| elicityl-oligotech | MAN810 | Mannan oligosaccharides (cut-off | 10mg | 2711.5 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 10mg | 2805 |
| elicityl-oligotech | FUC300 | Fucoidan polysaccharide from Chorda filum | 100mg | 2805 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 100mg | 2805 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 50mg | 2805 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 100mg | 2805 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 50mg | 2805 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 10mg | 2805 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 1mg | 2805 |
| elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 5mg | 2805 |
| elicityl-oligotech | GLY070-98% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>98% NMR) | 5mg | 2805 |
| elicityl-oligotech | GLY083-70% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>70% NMR) (Sodium salt) | 1mg | 2805 |
| elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 25mg | 3085.5 |
| elicityl-oligotech | FRU102-95% | Nystose (DP4) / GF3 (>95% NMR) | 25mg | 2898.5 |
| elicityl-oligotech | GLU302-98% | Cellotetraose (>98% HPAEC-PAD) | 10mg | 2898.5 |
| elicityl-oligotech | GLU511 | Curdlan polysaccharide β-(1-3) linked linear glucan prepared by bacterial fermentation | 1000mg | 2898.5 |
| elicityl-oligotech | GLY008-90% | N-Acetyl-D-Lactosamine (LacNAc) (>90% NMR) | 25mg | 2898.5 |
| elicityl-oligotech | GLY033-1-98% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>98% NMR) | 5mg | 2898.5 |
| elicityl-oligotech | FRU102-98% | Nystose (DP4) / GF3 (>98% HPAEC-PAD) | 25mg | 2992 |
| elicityl-oligotech | FRU112-90% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>90% HPAEC-PAD) | 5mg | 2992 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 100mg | 2992 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 100mg | 2992 |
| elicityl-oligotech | GLU410 | Chitin polysaccharide | 1000mg | 2992 |
| elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 10mg | 2992 |
| elicityl-oligotech | GLY008-80% | N-Acetyl-D-Lactosamine (LacNAc) (>80% NMR) | 25mg | 2992 |
| elicityl-oligotech | GLY045-70% | Lewis b (Leb) tetraose (>70% NMR) | 5mg | 2992 |
| elicityl-oligotech | GLY048-70% | Lewis Y (LeY) tetraose (>70% NMR) | 5mg | 2992 |
| elicityl-oligotech | GLY120-95% | Globotriaose (Gb3) / Pk antigen (>95% HPLC) | 5mg | 2992 |
| elicityl-oligotech | MAN800 | Mannan polysaccharide (Ivory Nut or Tagua) - 1.4-beta-D-Mannan | 1000mg | 2992 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 150mg | 2992 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 150mg | 3272.5 |
| elicityl-oligotech | ALG320 | Guluronate oligosaccharides average DP5 (sodium salt) | 10mg | 3272.5 |
| elicityl-oligotech | ALG520 | Mannuronate oligosaccharides Average DP5 (sodium salt) | 10mg | 3272.5 |
| elicityl-oligotech | FRU102-90% | Nystose (DP4) / GF3 (>90% NMR) | 25mg | 3085.5 |
| elicityl-oligotech | GLU313-99% | Maltotriose DP3 (>99% HPLC) | 100mg | 3085.5 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 100mg | 3085.5 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 50mg | 3085.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 25mg | 3085.5 |
| elicityl-oligotech | GLU700 | Scleroglucan polysaccharide | 10g | 3085.5 |
| elicityl-oligotech | GLY031-3-98% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>98% HPLC) | 5mg | 3085.5 |
| elicityl-oligotech | FRU101-95% | 1-Kestose (DP3) / GF2 (>95% HPAEC-PAD) | 25mg | 3179 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 10mg | 3179 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 10mg | 3179 |
| elicityl-oligotech | GLU312-95% | Maltose DP2 (>95% HPLC) | 1000mg | 3179 |
| elicityl-oligotech | GLU313-95% | Maltotriose DP3 (>95% HPLC) | 500mg | 3179 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 100mg | 3179 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 100mg | 3179 |
| elicityl-oligotech | GLU320-99% | Maltodecaose DP10 (>99% HPLC) | 1mg | 3179 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 5mg | 3179 |
| elicityl-oligotech | GLY009-95% | Lacto-N-Biose (>95% HPLC) | 5mg | 3179 |
| elicityl-oligotech | GLY122-85% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>85% NMR) | 5mg | 3179 |
| elicityl-oligotech | XYL100 | Xylan polysaccharide from Palmaria palmata | 1000mg | 3179 |
| elicityl-oligotech | GLY096-80% | GM1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 3459.5 |
| elicityl-oligotech | FRU117-60% | Fructo-oligosaccharide DP11 / GF10 (>60% HPAEC-PAD) | 10mg | 3272.5 |
| elicityl-oligotech | GAT100 | Galacturonate polysaccharides LM from apple (sodium salt) | 1000mg | 3272.5 |
| elicityl-oligotech | GAT111 | Galacturonan oligosaccharides Mixture DP3/DP4 | 10mg | 3272.5 |
| elicityl-oligotech | GLU303-90% | Cellopentaose (>90% HPAEC-PAD) | 10mg | 3272.5 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 25mg | 3272.5 |
| elicityl-oligotech | GLU421 | Chitosan oligosaccharides mixture | 100mg | 3272.5 |
| elicityl-oligotech | GLU434-90% | Chitin oligosaccharides DP4 / chitintetraose (>90% RMN) | 10mg | 3272.5 |
| elicityl-oligotech | GLY038-3-90% | Blood group B antigen tetraose type 5 (>90% NMR) | 5mg | 3272.5 |
| elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 5mg | 3272.5 |
| elicityl-oligotech | GLY083-90% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>90% NMR) (Sodium salt) | 1mg | 3272.5 |
| elicityl-oligotech | GLY120-98% | Globotriaose (Gb3) / Pk antigen (>98% HPLC) | 5mg | 3272.5 |
| elicityl-oligotech | GLY121-90% | Globotetraose (Gb4) / P antigen (>90% NMR) | 5mg | 3272.5 |
| elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 1mg | 3272.5 |
| elicityl-oligotech | GLY160 | Galactosyl-lactose | 5mg | 3272.5 |
| elicityl-oligotech | GLY161-90% | Difucosylpentaose | 5mg | 3272.5 |
| elicityl-oligotech | GLY162 | Disialosylpentaose | 5mg | 3272.5 |
| elicityl-oligotech | MAN213 | Galactomannan oligosaccharides DP3 from Carob | 10mg | 3272.5 |
| elicityl-oligotech | MAN215 | Galactomannan oligosaccharides DP5 from Carob | 10mg | 3272.5 |
| elicityl-oligotech | MAN300 | α-Digalactosyl mannopentaose | 10mg | 3272.5 |
| elicityl-oligotech | MAN801 | Acemannan polysaccharide (Aloe vera) | 10mg | 3272.5 |
| elicityl-oligotech | XYL101 | Glucurono-Arabinoxylan PLS from wheat bran | 100mg | 3272.5 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 150mg | 3272.5 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 100mg | 3366 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 25mg | 3366 |
| elicityl-oligotech | GLU324-95% | Maltoundecaose DP11 (>95% HPLC) | 5mg | 3366 |
| elicityl-oligotech | GLU324-99% | Maltoundecaose DP11 (>99% HPLC) | 5mg | 3366 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 5mg | 3366 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 25mg | 3366 |
| elicityl-oligotech | GLY045-80% | Lewisb (Leb) tetraose (>80% NMR) | 5mg | 3366 |
| elicityl-oligotech | GLY180-50% | Glucuronyl-lactose / HNK 1 epitope precursor (Sodium salt) | 5mg | 3366 |
| elicityl-oligotech | FRU101-90% | 1-Kestose (DP3) / GF2 (>90% NMR) | 50mg | 3459.5 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 10mg | 3459.5 |
| elicityl-oligotech | GLU312-98% | Maltose DP2 (>98% HPLC) | 1000mg | 3459.5 |
| elicityl-oligotech | GLU313-98% | Maltotriose DP3 (>98% HPLC) | 500mg | 3459.5 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 100mg | 3459.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 50mg | 3459.5 |
| elicityl-oligotech | GLU319-95% | Maltononaose DP9 (>95% HPLC) | 5mg | 3459.5 |
| elicityl-oligotech | GLU420 | Chitosan polysaccharide | 10000mg | 3459.5 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 5mg | 3459.5 |
| elicityl-oligotech | GLY081-85% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>85% NMR) (Sodium salt) | 5mg | 3459.5 |
| elicityl-oligotech | GLY221-AP | Galactose-β-Aminopropyl | 100mg | 3459.5 |
| elicityl-oligotech | ULV005 | Ulvan oligosaccharides (Cut-off: between 3 & 5kDa) from Enteromorpha sp. | 10mg | 3553 |
| elicityl-oligotech | ALG600 | Manuronic Block OLS. DP30-DP50 M/G ratio>4 | 25mg | 3646.5 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 100mg | 3646.5 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 100mg | 3646.5 |
| elicityl-oligotech | GLU326-95% | Maltododecaose DP12 (>95% HPLC) | 5mg | 3646.5 |
| elicityl-oligotech | GLU326-99% | Maltododecaose DP12 (>99% HPLC) | 5mg | 3646.5 |
| elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 10mg | 3646.5 |
| elicityl-oligotech | FRU102-90% | Nystose (DP4) / GF3 (>90% NMR) | 50mg | 3740 |
| elicityl-oligotech | GLU303-95% | Cellopentaose (>95% HPAEC-PAD) | 10mg | 3740 |
| elicityl-oligotech | GLU316-90% | Maltohexaose DP6 (>90% HPLC) | 250mg | 3740 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 250mg | 3740 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 25mg | 3740 |
| elicityl-oligotech | GLY143-99% | L-Fucose | 5000mg | 3740 |
| elicityl-oligotech | MAN200 | Galactomannan polysaccharides from Guar | 1000mg | 3740 |
| elicityl-oligotech | ALG530 | Mannuronate oligosaccharides DP3 (sodium salt) | 10mg | 4020.5 |
| elicityl-oligotech | GLU1000 | Xyloglucan oligosaccharides | 100mg | 3833.5 |
| elicityl-oligotech | GLU312-99% | Maltose DP2 (>99% HPLC) | 1000mg | 3833.5 |
| elicityl-oligotech | GLU313-99% | Maltotriose DP3 (>99% HPLC) | 500mg | 3833.5 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 250mg | 3833.5 |
| elicityl-oligotech | GLU327-98% | Maltotridecaose DP13 (>98% HPLC) | 5mg | 3833.5 |
| elicityl-oligotech | GLU327-99% | Maltotridecaose DP13 (>99% HPLC) | 5mg | 3833.5 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 5mg | 3833.5 |
| elicityl-oligotech | GLY008-80% | N-Acetyl-D-Lactosamine (LacNAc) (>80% NMR) | 100mg | 3833.5 |
| elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 10mg | 3833.5 |
| elicityl-oligotech | GLY132-90% | Forssman antigen pentaose | 1mg | 3833.5 |
| elicityl-oligotech | GLY097-80% | GM1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 4114 |
| elicityl-oligotech | GLY092-80% | GT3 Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 4114 |
| elicityl-oligotech | GLY096-90% | GM1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 250mg | 3927 |
| elicityl-oligotech | FRU117-70% | Fructo-oligosaccharide DP11 / GF10 (>70% HPAEC-PAD) | 10mg | 3927 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 25mg | 3927 |
| elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 10mg | 3927 |
| elicityl-oligotech | ALG330 | Guluronate oligosaccharides average DP3 (sodium salt) | 10mg | 4207.5 |
| elicityl-oligotech | GLU300-90% | Cellobiose (>90% HPAEC-PAD) | 100mg | 4020.5 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 100mg | 4020.5 |
| elicityl-oligotech | GLU319-98% | Maltononaose DP9 (>98% HPLC) | 5mg | 4020.5 |
| elicityl-oligotech | GLU319-99% | Maltononaose DP9 (>99% HPLC) | 5mg | 4020.5 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 50mg | 4020.5 |
| elicityl-oligotech | GLU320-98% | Maltodecaose DP10 (>98% HPLC) | 5mg | 4020.5 |
| elicityl-oligotech | GLY153-NPR | Galα1-3Gal-N-Acetyl-Propargyl | 5mg | 4020.5 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 10mg | 4114 |
| elicityl-oligotech | FUC200 | Galactofucan polysaccharide from Undaria pinnatifida | 100mg | 4114 |
| elicityl-oligotech | GAL101 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Fine grade | 100mg | 4114 |
| elicityl-oligotech | GAL111 | Sulfated Arabinogalactan oligosaccharides (Cut-off: between 3kDA & 10kDA) | 10mg | 4114 |
| elicityl-oligotech | GLU301-95% | Cellotriose (>95% HPAEC-PAD) | 50mg | 4114 |
| elicityl-oligotech | GLU304-80% | Cellohexaose (>80% HPAEC-PAD) | 10mg | 4114 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 100mg | 4114 |
| elicityl-oligotech | GLU436-90% | Chitin oligosaccharides DP6 / chitinhexaose (>90% RMN) | 10mg | 4114 |
| elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 10mg | 4114 |
| elicityl-oligotech | GLY035-3-90% | Blood group A antigen tetraose type 5 (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY046-75% | Lewis a (Lea) triaose | 5mg | 4114 |
| elicityl-oligotech | GLY048-90% | Lewis Y (LeY) tetraose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY049-90% | Lewis x (LeX) triaose /SSEA-1 / CD15 (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY050-90% | Lewis x (LeX) tetraose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY052-90% | Lewis y (LeY) pentaose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY054-90% | Lewis a (Lea) tetraose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY056-90% | Lewis b (Le b) pentaose (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | GLY102-90% | aGM1 (asialo GM1) Ganglioside oligosaccharide / GA1 (>90% NMR) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | GLY104-90% | aGM2 (asialo GM2) Ganglioside oligosaccharide / GA2 (>90% NMR) (Sodium salt) | 5mg | 4114 |
| elicityl-oligotech | GLY122-90% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>90% NMR) | 5mg | 4114 |
| elicityl-oligotech | GLY125-90% | Globo-B heptaose (>90% NMR) | 1mg | 4114 |
| elicityl-oligotech | GLY221-NPR | Galactose-NAc-propargyl | 100mg | 4114 |
| elicityl-oligotech | ULV006 | Ulvan oligosaccharides (Cut-off: between 1 & 3kDa ) from Enteromorpha sp. | 10mg | 4114 |
| elicityl-oligotech | ULV100 | Ulvan polysaccharides from Ulva sp. Native grade | 1000mg | 4114 |
| elicityl-oligotech | ULV101 | Ulvan polysaccharides from Enteromorpha sp. Native grade | 1000mg | 4114 |
| elicityl-oligotech | XYL111 | Xylan oligosaccharides XOs (Cut-off: between 650Da & 3kDa) from Palmaria p. | 10mg | 4114 |
| elicityl-oligotech | GLY097-90% | GM1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 4488 |
| elicityl-oligotech | FRU118-70% | Fructo-oligosaccharide DP12 / GF11 (>70% HPAEC-PAD) | 10mg | 4207.5 |
| elicityl-oligotech | GLU1161 | Reduced XLFG xyloglucan oligosaccharide (DP10) XLFGol | 50mg | 4207.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 250mg | 4207.5 |
| elicityl-oligotech | GLU328-99% | Maltotetradecaose DP14 (>99% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLU329-95% | Maltopentadecaose DP15 (>95% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLY040-1-90% | Blood group B antigen hexaose type 1 (>90% NMR) | 1mg | 4207.5 |
| elicityl-oligotech | GLY151-95% | GalNAcβ1-3Gal / Gb4 Globoside terminal | 5mg | 4207.5 |
| elicityl-oligotech | GLY155 | GlcNAcβ1-3Gal | 5mg | 4207.5 |
| elicityl-oligotech | GLU328-90% | Maltotetradecaose DP14 (>90% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLU329-90% | Maltopentadecaose DP15 (>90% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | GLU329-85% | Maltopentadecaose DP15 (>85% HPLC) | 5mg | 4207.5 |
| elicityl-oligotech | FRU110 | Fructo-oligosaccharides mixture from Jerusalem artichoke (Cut-off < 10kDa) | 1000mg | 4301 |
| elicityl-oligotech | GLU303-98% | Cellopentaose (>98% HPAEC-PAD) | 10mg | 4301 |
| elicityl-oligotech | GLY073-90% | Isoglobopentaose / iGb5 | 1mg | 4301 |
| elicityl-oligotech | FRU102-95% | Nystose (DP4) / GF3 (>95% NMR) | 50mg | 4394.5 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 50mg | 4394.5 |
| elicityl-oligotech | GLY033-2-90% | Blood group H antigen pentaose type 2 / Lacto-N-neofucopentaose I (LnNFP I) (>90% NMR) | 1mg | 4394.5 |
| elicityl-oligotech | GLU320-99% | Maltodecaose DP10 (>99% HPLC) | 5mg | 4488 |
| elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 5mg | 4488 |
| elicityl-oligotech | GLY030-80% | Blood group H antigen disaccharide (>80% NMR) | 25mg | 4488 |
| elicityl-oligotech | GLY032-1-70% | Blood group H antigen tetraose type 1 (>70% NMR) | 5mg | 4488 |
| elicityl-oligotech | GLY045-90% | Lewis b (Leb) tetraose (>90% NMR) | 5mg | 4488 |
| elicityl-oligotech | GLY062-80% | Lacto-N-fucopentaose V / LNFP V (>80% NMR) | 1mg | 4488 |
| elicityl-oligotech | GLY083-70% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>70% NMR) (Sodium salt) | 5mg | 4488 |
| elicityl-oligotech | GLY111-80% | GM2 Ganglioside oligosaccharide analogue (>80% NMR) (Sodium salt) | 1mg | 4488 |
| elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 1mg | 4488 |
| elicityl-oligotech | HGL101 | Sulfated heteropolysaccharides fine grade | 10mg | 4488 |
| elicityl-oligotech | GLU300-95% | Cellobiose (>95% HPAEC-PAD) | 100mg | 4581.5 |
| elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 10mg | 4581.5 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 250mg | 4955.5 |
| elicityl-oligotech | GLY099-80% | GD1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 4955.5 |
| elicityl-oligotech | GLY099-50% | GD1b Ganglioside oligosaccharide (>50%) (Sodium salt) | 1mg | 4955.5 |
| elicityl-oligotech | GLY096-95% | GM1a Ganglioside oligosaccharide (>95%) (Sodium salt) | 5mg | 4955.5 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 25mg | 4675 |
| elicityl-oligotech | GLY080 | Sialylated tetraose type 1 (Sodium salt) | 1mg | 4675 |
| elicityl-oligotech | GLY129-85% | Blood group B antigen pentasaccharide type 4 (>85% NMR) | 5mg | 4675 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 250mg | 4675 |
| elicityl-oligotech | GLU305-90% | Celloheptaose (>90% HPAEC-PAD) | 5mg | 4768.5 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 100mg | 4768.5 |
| elicityl-oligotech | GLY035-3-95% | Blood group A antigen tetraose type 5 (>95% NMR) | 5mg | 4768.5 |
| elicityl-oligotech | GLY046-85% | Lewis a (Lea) triaose | 5mg | 4768.5 |
| elicityl-oligotech | ALG601 | Manuronic Block OLS. DP20-DP35 M/G ratio>4 | 25mg | 4862 |
| elicityl-oligotech | ALG610 | Guluronate Block OLS. DP25-DP45 | 25mg | 4862 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 250mg | 4862 |
| elicityl-oligotech | GLY040-2-90% | Blood group B antigen hexaose type 2 (>90% NMR) | 1mg | 4862 |
| elicityl-oligotech | FRU101-95% | 1-Kestose (DP3) / GF2 (>95% HPAEC-PAD) | 50mg | 4955.5 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 25mg | 4955.5 |
| elicityl-oligotech | GLU304-90% | Cellohexaose (>90% HPAEC-PAD) | 10mg | 4955.5 |
| elicityl-oligotech | GLU310 | Maltodextrin High DP10-40 oligosaccharide mixture | 100mg | 4955.5 |
| elicityl-oligotech | GLU319-95% | Maltononaose DP9 (>95% HPLC) | 10mg | 4955.5 |
| elicityl-oligotech | GLY007-90% | Di-N-Acetyl-D-Lactosamine (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY008-90% | N-Acetyl-D-Lactosamine (LacNAc) (>90% NMR) | 100mg | 4955.5 |
| elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 1mg | 4955.5 |
| elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 1mg | 4955.5 |
| elicityl-oligotech | GLY047-90% | Sialyl LewisX (sLeX) tetraose (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY074-2-90% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY126-90% | Core type 4 (Gb5 triaose core structure) | 5mg | 4955.5 |
| elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 250mg | 4955.5 |
| elicityl-oligotech | GLY047-80% | Sialyl LewisX (sLeX) tetraose (>80% NMR) | 5mg | 4955.5 |
| elicityl-oligotech | GLY031-2-50% | Blood group H antigen triaose type 2 (>50% NMR) | 25mg | 5049 |
| elicityl-oligotech | GLU313-95% | Maltotriose DP3 (>95% HPLC) | 1000mg | 5142.5 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 25mg | 5142.5 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 25mg | 5142.5 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 100mg | 5142.5 |
| elicityl-oligotech | GLY011-95% | Lacto-N-Triaose (LNT2) (>95% HPLC) | 5mg | 5142.5 |
| elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 1mg | 5142.5 |
| elicityl-oligotech | GLY037-2-90% | Blood group A antigen hexaose type 2 (>90% NMR) | 1mg | 5142.5 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 25mg | 5236 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 250mg | 5236 |
| elicityl-oligotech | GLY032-1-80% | Blood group H antigen tetraose type 1 (>80% NMR) | 5mg | 5236 |
| elicityl-oligotech | GLY142 | N-acetylmannosamine | 5000mg | 5236 |
| elicityl-oligotech | FRU102-98% | Nystose (DP4) / GF3 (>98% HPAEC-PAD) | 50mg | 5329.5 |
| elicityl-oligotech | FRU112-90% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>90% HPAEC-PAD) | 10mg | 5329.5 |
| elicityl-oligotech | FRU116-90% | Fructo-oligosaccharide DP10 / GF9 (>90% HPAEC-PAD) | 5mg | 5329.5 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 10mg | 5329.5 |
| elicityl-oligotech | GLY036-1-80% | Blood group A antigen pentaose type 1 (>80% NMR) | 1mg | 5329.5 |
| elicityl-oligotech | GLY072-90% | Isoglobotetraose / iGb4 / Cytolipin R (>90% NMR) | 1mg | 5329.5 |
| elicityl-oligotech | GLY111-90% | GM2 Ganglioside oligosaccharide analogue (>90% NMR) (Sodium salt) | 1mg | 5329.5 |
| elicityl-oligotech | GLY124-90% | Globo-A heptaose | 1mg | 5329.5 |
| elicityl-oligotech | GLY095-80% | GT2 Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 5797 |
| elicityl-oligotech | GLY100-80% | GT1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 1mg | 5797 |
| elicityl-oligotech | GAL112 | Sulfated Arabinogalactan oligosaccharides (cut-off < 3kDa) | 10mg | 5516.5 |
| elicityl-oligotech | GLU305-95% | Celloheptaose (>95% HPAEC-PAD) | 5mg | 5516.5 |
| elicityl-oligotech | GLU313-98% | Maltotriose DP3 (>98% HPLC) | 1000mg | 5516.5 |
| elicityl-oligotech | GLU320-98% | Maltodecaose DP10 (>98% HPLC) | 10mg | 5516.5 |
| elicityl-oligotech | GLU323 | Cellodextrin Oligosaccharide mixture DP | 100mg | 5516.5 |
| elicityl-oligotech | ULV007 | Ulvan oligosaccharides (Cut-off: between 650Da & 1kDa) from Enteromorpha sp. | 10mg | 5516.5 |
| elicityl-oligotech | ALG100 | Alginate polysaccharides (from Laminaria japonica) | 1000mg | 5984 |
| elicityl-oligotech | ALG101 | Alginate polysaccharides (from Fucus vesiculosus) | 10000mg | 5984 |
| elicityl-oligotech | ALG102 | Alginate polysaccharides (from Ascophyllum nodosum) | 10000mg | 5984 |
| elicityl-oligotech | ALG310 | Guluronate oligosaccharides average DP10 (sodium salt) | 25mg | 6077.5 |
| elicityl-oligotech | ALG510 | Mannuronate oligosaccharides Average DP10 (sodium salt) | 25mg | 6077.5 |
| elicityl-oligotech | GLU200 | Xanthan gum polysaccharide | 1000mg | 5703.5 |
| elicityl-oligotech | GLU304-95% | Cellohexaose (>95% HPAEC-PAD) | 10mg | 5703.5 |
| elicityl-oligotech | GLU324-95% | Maltoundecaose DP11 (>95% HPLC) | 10mg | 5703.5 |
| elicityl-oligotech | GLU324-99% | Maltoundecaose DP11 (>99% HPLC) | 10mg | 5703.5 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 10mg | 5703.5 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 50mg | 5703.5 |
| elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 25mg | 5703.5 |
| elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 1mg | 5703.5 |
| elicityl-oligotech | GLY074-2-95% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>95% NMR) | 5mg | 5703.5 |
| elicityl-oligotech | GLY153-90% | α1-3 galactobiose / Galα1-3Gal (>90% NMR) | 25mg | 5703.5 |
| elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 5mg | 5703.5 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 50mg | 5797 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 250mg | 5797 |
| elicityl-oligotech | GLY023-95% | Lacto-N-neooctaose (LNnO) (>95% HPLC) | 1mg | 5797 |
| elicityl-oligotech | GLY039-2-90% | Blood group B antigen pentaose type 2 (>90% NMR) | 1mg | 5797 |
| elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 1mg | 5797 |
| elicityl-oligotech | GLY083-90% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>90% NMR) (Sodium salt) | 5mg | 5797 |
| elicityl-oligotech | GLY101-80% | GT1c Ganglioside oligosaccharide (>80% NMR) (Sodium salt) | 1mg | 5797 |
| elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 1mg | 5797 |
| elicityl-oligotech | GLY038-4-80% | Blood group B Lewisb antigen pentaose type 1 (>80% NMR) | 5mg | 5890.5 |
| elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 10mg | 5890.5 |
| elicityl-oligotech | GLY074-1-80% | Xeno antigen type 1 (>80% NMR) | 5mg | 5890.5 |
| elicityl-oligotech | GLY120-98% | Globotriaose (Gb3) / Pk antigen (>98% HPLC) | 10mg | 5890.5 |
| elicityl-oligotech | GLY251 | Galα1-4Galα1-4Galα1-4Galβ1-4Glc/ Galα1-4Galα1-4Gb3 | 1mg | 5890.5 |
| elicityl-oligotech | FUC100 | Fucoidan polysaccharide from Fucus vesiculosus | 100mg | 5984 |
| elicityl-oligotech | GLU422 | Chitosan oligosaccharide - average DP60 | 100mg | 5984 |
| elicityl-oligotech | GLU423 | Chitosan oligosaccharide - average DP40 | 100mg | 5984 |
| elicityl-oligotech | GLU424 | Chitosan oligosaccharide - average DP24 | 100mg | 5984 |
| elicityl-oligotech | GLY030-90% | Blood group H antigen disaccharide (>90% NMR) | 25mg | 5984 |
| elicityl-oligotech | GLY063 | 3’Sialyl-3Fucosyllactose / F-SL (Sodium salt) | 5mg | 5984 |
| elicityl-oligotech | GLY129-90% | Blood group B antigen pentasaccharide type 4 (>90% NMR) | 5mg | 5984 |
| elicityl-oligotech | GLY163-80% | 2'2 Difucosyllactose (>80% NMR) | 5mg | 5984 |
| elicityl-oligotech | GLY165-80% | Fucosylated B antigen type 5 (>80% NMR) | 5mg | 5984 |
| elicityl-oligotech | GLY092-90% | GT3 Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLY099-90% | GD1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLY098-90% | GD1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6451.5 |
| elicityl-oligotech | GLU313-99% | Maltotriose DP3 (>99% HPLC) | 1000mg | 6077.5 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 250mg | 6077.5 |
| elicityl-oligotech | GLU316-90% | Maltohexaose DP6 (>90% HPLC) | 500mg | 6077.5 |
| elicityl-oligotech | GLU326-95% | Maltododecaose DP12 (>95% HPLC) | 10mg | 6077.5 |
| elicityl-oligotech | GLU326-99% | Maltododecaose DP12 (>99% HPLC) | 10mg | 6077.5 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 50mg | 6077.5 |
| elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 1mg | 6077.5 |
| elicityl-oligotech | GLY082-85% | Sialylated tetraose type 2 (Sodium salt) (>85% NMR) | 1mg | 6077.5 |
| elicityl-oligotech | GLY136 | Globotriaose analogue type 2/ P1 antigen | 1mg | 6077.5 |
| elicityl-oligotech | GLY100-90% | GT1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6545 |
| elicityl-oligotech | GLY095-90% | GT2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 1mg | 6545 |
| elicityl-oligotech | FRU113-95% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>95% HPAEC-PAD) | 5mg | 6171 |
| elicityl-oligotech | FRU113-90% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>90% HPAEC-PAD) | 5mg | 6171 |
| elicityl-oligotech | ARB106 | Arabinan polysaccharides from sugar Beet | 1000mg | 6264.5 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 25mg | 6264.5 |
| elicityl-oligotech | FRU112-95% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>95% HPAEC-PAD) | 5mg | 6264.5 |
| elicityl-oligotech | GLU1110 | XFG xyloglucan oligosaccharide (DP7) | 10mg | 6264.5 |
| elicityl-oligotech | GLU1160 | XLFG xyloglucan oligosaccharide (DP10) | 10mg | 6264.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 250mg | 6264.5 |
| elicityl-oligotech | GLU318-90% | Maltooctaose DP8 (>90% HPLC) | 500mg | 6264.5 |
| elicityl-oligotech | GLY007-2-85% | Tri-N-Acetyl-D-Lactosamine (>85% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY023-98% | Lacto-N-neooctaose (LNnO) (>98% HPLC) | 1mg | 6264.5 |
| elicityl-oligotech | GLY024-90% | Galacto-N-Neopentaose Di LAcNac Gal (>90% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-70% | Blood group H antigen triaose type 1 (>70% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-80% | Blood group H antigen triaose type 1 (>80% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-90% | Blood group H antigen triaose type 1 (>90% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-1-95% | Blood group H antigen triaose type 1 (>95% NMR) | 5mg | 6264.5 |
| elicityl-oligotech | GLY031-2-50% | Blood group H antigen triaose type 2 (>50% NMR) | 50mg | 6264.5 |
| elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 1mg | 6264.5 |
| elicityl-oligotech | GLY172-85% | Disialylated pentaose type 1 | 1mg | 6264.5 |
| elicityl-oligotech | GLY092-80% | GT3 Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 6732 |
| elicityl-oligotech | GLU305-98% | Celloheptaose (>98% HPAEC-PAD) | 5mg | 6358 |
| elicityl-oligotech | GLY036-2-90% | Blood group A antigen pentaose type 2 (>90% NMR) | 1mg | 6358 |
| elicityl-oligotech | GLY039-1-90% | Blood group B antigen pentaose type 1 (>90% NMR) | 1mg | 6358 |
| elicityl-oligotech | GLY081-85% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>85% NMR) (Sodium salt) | 10mg | 6358 |
| elicityl-oligotech | GLY134-90% | Isoforssman antigen pentaose | 1mg | 6358 |
| elicityl-oligotech | GLY171-85% | Sialylated globotriose/ 3Sialyl-Gb3 | 1mg | 6358 |
| elicityl-oligotech | GLY036-1-85% | Blood group A antigen pentaose type 1 (>85% NMR) | 1mg | 6358 |
| elicityl-oligotech | ALG500 | Mannuronate oligosaccharides Average DP20 (sodium salt) | 100mg | 6825.5 |
| elicityl-oligotech | FRU114-90% | Fructo-oligosaccharide DP8 / GF7 (>90% HPAEC-PAD) | 5mg | 6451.5 |
| elicityl-oligotech | FRU118-90% | Fructo-oligosaccharide DP12 / GF11 (>90% HPAEC-PAD) | 10mg | 6451.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 250mg | 6451.5 |
| elicityl-oligotech | GLU317-90% | Maltoheptaose DP7 (>90% HPLC) | 500mg | 6451.5 |
| elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 25mg | 6451.5 |
| elicityl-oligotech | GLY071-90% | Galili antigen pentaose (>90% NMR) | 1mg | 6451.5 |
| elicityl-oligotech | GLY078-85% | Galili antigen nonaose (>85% NMR) | 1mg | 6451.5 |
| elicityl-oligotech | GLY131-90% | SSEA-4 hexaose / Stage-Specific Embryonic Antigen-4 hexaose (>90% NMR) | 1mg | 6451.5 |
| elicityl-oligotech | GLY174-90% | GalGalNac-aGM1 (GalGalNAc asialo GM1) Ganglioside oligosaccharide analogue | 1mg | 6451.5 |
| elicityl-oligotech | FRU114-95% | Fructo-oligosaccharide DP8 / GF7 (>95% HPAEC-PAD) | 5mg | 6451.5 |
| elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 100mg | 6919 |
| elicityl-oligotech | GAT122 | Galacturonan Oligosaccharide DP2 | 10mg | 6545 |
| elicityl-oligotech | GAT123 | Galacturonan Oligosaccharide DP3 | 10mg | 6545 |
| elicityl-oligotech | GAT124 | Galacturonan Oligosaccharide DP4 | 10mg | 6545 |
| elicityl-oligotech | GLU304-98% | Cellohexaose (>98% HPAEC-PAD) | 10mg | 6545 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 10mg | 6545 |
| elicityl-oligotech | GLY040-1-90% | Blood group B antigen hexaose type 1 (>90% NMR) | 5mg | 6545 |
| elicityl-oligotech | GLY040-2-90% | Blood group B antigen hexaose type 2 (>90% NMR) | 5mg | 6545 |
| elicityl-oligotech | GLY101-90% | GT1c Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 1mg | 6545 |
| elicityl-oligotech | LEC101 | LecB (PA-IIL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 1mg | 6545 |
| elicityl-oligotech | LEC102 | LecA (PA-IL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 1mg | 6545 |
| elicityl-oligotech | ULV102 | Ulvan polysaccharides from Ulva sp. Fine grade | 100mg | 6545 |
| elicityl-oligotech | ULV103 | Ulvan polysaccharides from Enteromorpha sp. Fine grade | 100mg | 6545 |
| elicityl-oligotech | ALG320 | Guluronate oligosaccharides average DP5 (sodium salt) | 25mg | 7199.5 |
| elicityl-oligotech | ALG520 | Mannuronate oligosaccharides Average DP5 (sodium salt) | 25mg | 7199.5 |
| elicityl-oligotech | GLU1140 | XLLG oligosaccharide | 10mg | 6732 |
| elicityl-oligotech | GLU1161 | Reduced XLFG xyloglucan oligosaccharide (DP10) XLFGol | 100mg | 6732 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 250mg | 6732 |
| elicityl-oligotech | GLU316-95% | Maltohexaose DP6 (>95% HPLC) | 500mg | 6732 |
| elicityl-oligotech | GLU311 | Maltodextrin oligosaccharide mixture | 100mg | 6825.5 |
| elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY031-3-85% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>85% NMR) | 25mg | 6825.5 |
| elicityl-oligotech | GLY032-1-90% | Blood group H antigen tetraose type 1 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY034-90% | Blood group A antigen triaose | 5mg | 6825.5 |
| elicityl-oligotech | GLY036-1-90% | Blood group A antigen pentaose type 1 (>90% NMR) | 1mg | 6825.5 |
| elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY037-2-90% | Blood group A antigen hexaose type 2 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY038-1-90% | Blood group B antigen tetraose type 1 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY038-2-90% | Blood group B antigen tetraose type 2 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY084-2-90% | Sialylated triaose type 2/ 3'-α-sialyl-Acetyl-Lactosamine/ sialyl Lex precursor (>90% NMR) (Sodium salt) | 5mg | 6825.5 |
| elicityl-oligotech | GLY123-90% | Globo-H hexaose / Stage Specific Embryonic Antigen 3b (SSEA-3b) (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY128-90% | Blood group A antigen pentaose type 4 (>90% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY220-NPR | Lactose-β-NAc-propargyl | 25mg | 6825.5 |
| elicityl-oligotech | GLY250-80% | Galα1-4Galα1-4Galβ1-4Glc / Galα1-4Gb3 (> 80% NMR) | 5mg | 6825.5 |
| elicityl-oligotech | GLY094-95% | GD2 Ganglioside oligosaccharide (>95%) (Sodium salt) | 1mg | 7386.5 |
| elicityl-oligotech | ALG342 | Guluronate oligosaccharides DP2 (sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | ALG343 | Guluronate oligosaccharides DP3 (sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | ALG344 | Guluronate oligosaccharides DP4 (sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 250mg | 6919 |
| elicityl-oligotech | GLU327-98% | Maltotridecaose DP13 (>98% HPLC) | 10mg | 6919 |
| elicityl-oligotech | GLU327-99% | Maltotridecaose DP13 (>99% HPLC) | 10mg | 6919 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 10mg | 6919 |
| elicityl-oligotech | GLU411 | Colloidal Chitin polysaccharide | 1000mg | 6919 |
| elicityl-oligotech | GLY034-NAc-sp1-NH2 | Blood group A antigen triaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 6919 |
| elicityl-oligotech | GLY034-NAc-sp2-NH2 | Blood group A antigen triaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG7-NH2 | 1mg | 6919 |
| elicityl-oligotech | GLY034-APTFAc | Blood group A antigen triaose-β-O-aminopropyl trifluoroacetate | 1mg | 6919 |
| elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 25mg | 6919 |
| elicityl-oligotech | GLY077-90% | Galili antigen heptaose (>90% NMR) | 1mg | 6919 |
| elicityl-oligotech | GLY141 | N-acetylgalactosamine | 5000mg | 6919 |
| elicityl-oligotech | GLY038-5-70% | Blood group B LewisY antigen pentaose type 2 (>70% NMR) | 5mg | 6919 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 25mg | 6919 |
| elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 25mg | 6919 |
| elicityl-oligotech | GLU1150 | XXFG oligosaccharide | 10mg | 7012.5 |
| elicityl-oligotech | GLU427 | Chitosan oligosaccharide - average DP15-20 | 100mg | 7012.5 |
| elicityl-oligotech | GLY035-1-90% | Blood group A antigen tetraose type 1 (>90% NMR) | 5mg | 7012.5 |
| elicityl-oligotech | GLY195-2 | SSEA-4 hexaose analogue type 2 | 5mg | 7012.5 |
| elicityl-oligotech | GLY197 | Isoglobotetraose analogue / iGb4 analogue | 5mg | 7012.5 |
| elicityl-oligotech | ARB105 | Arabinan polysaccharides from Apple | 1000mg | 7106 |
| elicityl-oligotech | FRU115-90% | Fructo-oligosaccharide DP9 / GF8 (>90% HPAEC-PAD) | 5mg | 7106 |
| elicityl-oligotech | GLY064-60% | α-3Galactosyl-3Fucosyllactose (>60% NMR) | 5mg | 7106 |
| elicityl-oligotech | GLY078-90% | Galili antigen nonaose (>90% NMR) | 1mg | 7106 |
| elicityl-oligotech | FRU115-95% | Fructo-oligosaccharide DP9 / GF8 (>95% HPAEC-PAD) | 5mg | 7106 |
| elicityl-oligotech | GLY091-90% | GD3 Ganglioside oligosaccharide / Disialyl lactose/ DS-L (>90%) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLY093-90% | GM2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 250mg | 7199.5 |
| elicityl-oligotech | GLU319-98% | Maltononaose DP9 (>98% HPLC) | 10mg | 7199.5 |
| elicityl-oligotech | GLU319-99% | Maltononaose DP9 (>99% HPLC) | 10mg | 7199.5 |
| elicityl-oligotech | GLY024-95% | Galacto-N-Neopentaose Di LAcNac Gal (>95% NMR) | 5mg | 7199.5 |
| elicityl-oligotech | GLY132-90% | Forssman antigen pentaose | 5mg | 7199.5 |
| elicityl-oligotech | GLY140-90% | Sialic acid (N-acetylneuraminic acid) (>90% NMR) | 5000mg | 7199.5 |
| elicityl-oligotech | LEC101-Bt | LecB (PA-IIL) from Pseudomonas aeruginosa linked to Biotin - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | LEC102-Bt | LecA (PA-IL) from Pseudomonas aeruginosa linked to Biotin - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | LEC202 | RSL from Ralstonia solanacearum - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | LEC301 | BC2LA from Burkholderia cenocepacia - (Bacterial protein produced in E. coli) | 1mg | 7199.5 |
| elicityl-oligotech | GLU328-99% | Maltotetradecaose DP14 (>99% HPLC) | 10mg | 7293 |
| elicityl-oligotech | FRU116-95% | Fructo-oligosaccharide DP10 / GF9 (>95% HPAEC-PAD) | 5mg | 7293 |
| elicityl-oligotech | GLU328-90% | Maltotetradecaose DP14 (>90% HPLC) | 10mg | 7293 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 25mg | 7386.5 |
| elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 5mg | 7386.5 |
| elicityl-oligotech | GLY052-90% | Lewis y (LeY) pentaose (>90% NMR) | 10mg | 7386.5 |
| elicityl-oligotech | GLY054-90% | Lewis a (Lea) tetraose (>90% NMR) | 10mg | 7386.5 |
| elicityl-oligotech | GLY071-95% | Galili antigen pentaose (>95% NMR) | 1mg | 7386.5 |
| elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | GLY102-90% | aGM1 (asialo GM1) Ganglioside oligosaccharide / GA1 (>90% NMR) (Sodium salt) | 10mg | 7386.5 |
| elicityl-oligotech | GLY092-90% | GT3 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 7947.5 |
| elicityl-oligotech | GLU329-95% | Maltopentadecaose DP15 (>95% HPLC) | 10mg | 7480 |
| elicityl-oligotech | GLY111-80% | GM2 Ganglioside oligosaccharide analogue (>80% NMR) (Sodium salt) | 5mg | 7480 |
| elicityl-oligotech | GLU329-90% | Maltopentadecaose DP15 (>90% HPLC) | 10mg | 7480 |
| elicityl-oligotech | GLU329-85% | Maltopentadecaose DP15 (>85% HPLC) | 10mg | 7480 |
| elicityl-oligotech | GLY038-4-85% | Blood group B Lewisb antigen pentaose type 1 (>85% NMR) | 5mg | 7480 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 250mg | 7573.5 |
| elicityl-oligotech | GLY230-90% | 2’FucosylLactulose / 2’FLactulose | 5mg | 7573.5 |
| elicityl-oligotech | GLY097-80% | GM1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 8134.5 |
| elicityl-oligotech | GLY005-90% | Core type 1 triaose | 5mg | 7667 |
| elicityl-oligotech | GLY006-90% | Core type 2 triaose | 5mg | 7667 |
| elicityl-oligotech | GLY007-3-90% | Tetra-N-Acetyl-D-Lactosamine | 5mg | 7667 |
| elicityl-oligotech | GLY012-90% | Para-Lacto-N-hexaose (Para-LNH) | 5mg | 7667 |
| elicityl-oligotech | GLY033-2-90% | Blood group H antigen pentaose type 2 / Lacto-N-neofucopentaose I (LnNFP I) (>90% NMR) | 5mg | 7667 |
| elicityl-oligotech | GLY035-2-90% | Blood group A antigen tetraose type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY035-4-90% | Blood group A Lewisb antigen pentaose type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY035-5-85% | Blood group A LewisY antigen pentaose type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY067-70% | 3-Fucosylated Blood group A tetraose | 5mg | 7667 |
| elicityl-oligotech | GLY068 | 3-Fucosylated Blood group B tetraose | 5mg | 7667 |
| elicityl-oligotech | GLY074-1-85% | Xeno antigen type 1 (>85% NMR) | 5mg | 7667 |
| elicityl-oligotech | GLY075-90% | Xeno lewisX / α-Gal-LewisX | 5mg | 7667 |
| elicityl-oligotech | GLY103-90% | Fucosyl GM1 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLY127-90% | Blood group H antigen tetraose type 4 / Globo H tetraose -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 7667 |
| elicityl-oligotech | GLY130-85% | SSEA-4 tetraose / Stage-Specific Embryonic Antigen-4 tetraose | 5mg | 7667 |
| elicityl-oligotech | GLY133-90% | Forssman antigen triaose | 5mg | 7667 |
| elicityl-oligotech | GLY164 | Fucosylated A antigen type 5 | 5mg | 7667 |
| elicityl-oligotech | GLY165-90% | Fucosylated B antigen type 5 (>90% NMR) | 5mg | 7667 |
| elicityl-oligotech | GLY181-90% | Glucuronyl-LNT / Glucuronyl-Lacto-N-tetraose (>90% NMR) (Sodium salt) | 5mg | 7667 |
| elicityl-oligotech | GLY190 | Globotetraose analogue / Gb4 analogue | 5mg | 7667 |
| elicityl-oligotech | GLY191-1-90% | Globopentaose analogue type 1 / Gb5 analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY191-2-90% | Globopentaose analogue type 2 / Gb5 analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY194-1 | Globo-H analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY194-2-90% | Globo-H analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY195-1 | SSEA-4 hexaose analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY196-1-75% | Sialylated-SSEA-4 hexaose analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY198-1 | Isoglobopentaose analogue type 1 / iGb5 analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY201-1 | Isoglobo-H analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY201-2 | Isoglobo-H analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLY202-1 | Sialylated isoglobopentaose analogue type 1 / Sialylated iGb5 analogue type 1 | 5mg | 7667 |
| elicityl-oligotech | GLY202-2 | Sialylated isoglobopentaose analogue type 2 / Sialylated iGb5 analogue type 2 | 5mg | 7667 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 50mg | 7760.5 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 50mg | 7760.5 |
| elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 25mg | 7760.5 |
| elicityl-oligotech | GLY038-4-90% | Blood group B Lewisb antigen pentaose type 1 (>90% NMR) | 5mg | 7760.5 |
| elicityl-oligotech | GLY038-5-90% | Blood group B LewisY antigen pentaose type 2 | 5mg | 7760.5 |
| elicityl-oligotech | GLY072-90% | Isoglobotetraose / iGb4 / Cytolipin R (>90% NMR) | 5mg | 7760.5 |
| elicityl-oligotech | GLY163-90% | 2'2 Difucosyllactose (>90% NMR) | 5mg | 7760.5 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 250mg | 7854 |
| elicityl-oligotech | GLU410 | Chitin polysaccharide | 10000mg | 7854 |
| elicityl-oligotech | GLY024-98% | Galacto-N-Neopentaose Di LAcNac Gal (>98% NMR) | 5mg | 7854 |
| elicityl-oligotech | GLY080 | Sialylated tetraose type 1 (Sodium salt) | 5mg | 7854 |
| elicityl-oligotech | LEC101-FITC | LecB (PA-IIL) from Pseudomonas aeruginosa linked to FITC - (Bacterial protein produced in E. coli) | 1mg | 7854 |
| elicityl-oligotech | LEC101-FITC | copy of LecA (PA-IL) from Pseudomonas aeruginosa linked to FITC - (Bacterial protein produced in E. coli) | 1mg | 7854 |
| elicityl-oligotech | LEC102-FITC | copy of LecB (PA-IIL) from Pseudomonas aeruginosa linked to FITC - (Bacterial protein produced in E. coli) | 1mg | 7854 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 500mg | 8415 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 250mg | 7947.5 |
| elicityl-oligotech | GLU425 | Chitosan oligosaccharide - average DP12 | 100mg | 8041 |
| elicityl-oligotech | GLU426 | Chitosan oligosaccharide - average DP6 | 100mg | 8041 |
| elicityl-oligotech | GLY070-95% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>95% NMR) | 25mg | 8041 |
| elicityl-oligotech | GLY077-95% | Galili antigen heptaose (>95% NMR) | 1mg | 8041 |
| elicityl-oligotech | MAN201 | Galactomannan polysaccharides from Carob (locust bean gum) | 10000mg | 8041 |
| elicityl-oligotech | MAN202 | Galactomannan polysaccharide from Fenugreek | 1000mg | 8041 |
| elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 10mg | 8134.5 |
| elicityl-oligotech | GLY073-90% | Isoglobopentaose / iGb5 | 5mg | 8134.5 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 500mg | 8134.5 |
| elicityl-oligotech | ALG542 | Manuronate oligosaccharide DP2 (sodium salt) | 10mg | 8228 |
| elicityl-oligotech | ALG543 | Manuronate oligosaccharide DP3 (sodium salt) | 10mg | 8228 |
| elicityl-oligotech | ALG544 | Manuronate oligosaccharide DP4 (sodium salt) | 10mg | 8228 |
| elicityl-oligotech | GAL100 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Native grade | 5000mg | 8228 |
| elicityl-oligotech | GLU306-90% | Cellooctaose (>90% HPAEC-PAD) | 5mg | 8228 |
| elicityl-oligotech | GLU320-99% | Maltodecaose DP10 (>99% HPLC) | 10mg | 8228 |
| elicityl-oligotech | GLY032-2-90% | Blood group H antigen tetraose type 2 (>90% NMR) | 5mg | 8228 |
| elicityl-oligotech | GLY062-80% | Lacto-N-fucopentaose V / LNFP V (>80% NMR) | 5mg | 8228 |
| elicityl-oligotech | ALG530 | Mannuronate oligosaccharides DP3 (sodium salt) | 25mg | 8882.5 |
| elicityl-oligotech | FRU111-90% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>90% NMR) | 50mg | 8321.5 |
| elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 25mg | 8321.5 |
| elicityl-oligotech | GLY079-90% | Galili antigen undecaose (>90% NMR) | 1mg | 8321.5 |
| elicityl-oligotech | GLU900 | Pustulan polysaccharide | 1000mg | 8415 |
| elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 500mg | 8415 |
| elicityl-oligotech | ALG330 | Guluronate oligosaccharides average DP3 (sodium salt) | 25mg | 9163 |
| elicityl-oligotech | GLU1111 | Reduced XFG xyloglucan oligosaccharide (DP7) XFGol | 100mg | 8602 |
| elicityl-oligotech | GLU305-90% | Celloheptaose (>90% HPAEC-PAD) | 10mg | 8602 |
| elicityl-oligotech | GLY031-2-95% | Blood group H antigen triaose type 2 (>95% NMR) | 25mg | 8602 |
| elicityl-oligotech | GLY070-98% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>98% NMR) | 25mg | 8602 |
| elicityl-oligotech | GLY155 | GlcNAcβ1-3Gal | 25mg | 8602 |
| elicityl-oligotech | GLY031-2-90% | Blood group H antigen triaose type 2 (>90% NMR) | 25mg | 8602 |
| elicityl-oligotech | GLY097-90% | GM1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 9350 |
| elicityl-oligotech | GLY030-AP | Blood group H antigen disaccharide-O-aminopropyl | 1mg | 8789 |
| elicityl-oligotech | GLY126-AP | Core type 4 (Gb5 triaose core structure)-aminopropyl | 1mg | 8789 |
| elicityl-oligotech | GLY090-GEL | 3'-Sialyllactose grafted on gel matrix (3'SL-Gel) 1 ml | 1mg | 9443.5 |
| elicityl-oligotech | ALG600 | Manuronic Block OLS. DP30-DP50 M/G ratio>4 | 100mg | 8882.5 |
| elicityl-oligotech | FRU114-70% | Fructo-oligosaccharide DP8 / GF7 (>70% HPAEC-PAD) | 50mg | 8882.5 |
| elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 25mg | 8882.5 |
| elicityl-oligotech | GLY060-BSA | 3 Fucosyllactose linked to BSA | 1mg | 8882.5 |
| elicityl-oligotech | GLY090-AP | 3'-Sialyllactose-β-Aminopropyl / GM3 Ganglioside oligosaccharide-β-aminopropyl (Sodium salt) | 1mg | 9537 |
| elicityl-oligotech | GLU317-95% | Maltoheptaose DP7 (>95% HPLC) | 500mg | 8976 |
| elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 250mg | 8976 |
| elicityl-oligotech | GLY047-90% | Sialyl LewisX (sLeX) tetraose (>90% NMR) | 10mg | 8976 |
| elicityl-oligotech | GLY047-80% | Sialyl LewisX (sLeX) tetraose (>80% NMR) | 10mg | 8976 |
| elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 100mg | 9069.5 |
| elicityl-oligotech | GLY124-90% | Globo-A heptaose | 5mg | 9069.5 |
| elicityl-oligotech | GLU316-98% | Maltohexaose DP6 (>98% HPLC) | 500mg | 9163 |
| elicityl-oligotech | GLU436-90% | Chitin oligosaccharides DP6 / chitinhexaose (>90% RMN) | 25mg | 9163 |
| elicityl-oligotech | GLY009-90% | Lacto-N-Biose (>90% HPLC) | 25mg | 9163 |
| elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 25mg | 9163 |
| elicityl-oligotech | GLY111-90% | GM2 Ganglioside oligosaccharide analogue (>90% NMR) (Sodium salt) | 5mg | 9256.5 |
| elicityl-oligotech | GLY125-90% | Globo-B heptaose (>90% NMR) | 5mg | 9256.5 |
| elicityl-oligotech | ALG103 | Alginate polysaccharides (from Chorda filum) | 10000mg | 10004.5 |
| elicityl-oligotech | ALG104 | Alginate polysaccharides (from Durvillaea antarctica) | 10000mg | 10004.5 |
| elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 50mg | 9443.5 |
| elicityl-oligotech | GLU306-95% | Cellooctaose (>95% HPAEC-PAD) | 5mg | 9443.5 |
| elicityl-oligotech | FRU116-90% | Fructo-oligosaccharide DP10 / GF9 (>90% HPAEC-PAD) | 10mg | 9537 |
| elicityl-oligotech | GLY154-NPR | α1-4 galactobiose-NAc-propargyl | 1mg | 9537 |
| elicityl-oligotech | FRU112-90% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>90% HPAEC-PAD) | 25mg | 9630.5 |
| elicityl-oligotech | GLY006-NPR | Core type 2 triaose-β-N-acetyl-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY010-NPR | Lacto-N-tetraose-β-N-acetyl-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 25mg | 9630.5 |
| elicityl-oligotech | GLY021-NPR | LNnT-β-N-acetyl-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY031-3-NPR | 2'FL-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY120-NPR | Globotriaose (Gb3)-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY122-NPR | Globopentaose (Gb5)-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY134-90% | Isoforssman antigen pentaose | 5mg | 9630.5 |
| elicityl-oligotech | GLY151-AP | GalNAcβ1-3Gal-aminopropyl | 5mg | 9630.5 |
| elicityl-oligotech | GLY250-NPR | Galα1-4Galα1-4Galβ1-4Glc-NAc-propargyl | 1mg | 9630.5 |
| elicityl-oligotech | GLY033-1-90% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>90% NMR) | 25mg | 9724 |
| elicityl-oligotech | GLU303-95% | Cellopentaose (>95% HPAEC-PAD) | 50mg | 9817.5 |
| elicityl-oligotech | GLY031-3-98% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>98% HPLC) | 25mg | 9817.5 |
| elicityl-oligotech | GLU305-95% | Celloheptaose (>95% HPAEC-PAD) | 10mg | 9911 |
| elicityl-oligotech | GLU319-95% | Maltononaose DP9 (>95% HPLC) | 25mg | 9911 |
| elicityl-oligotech | GLY036-1-80% | Blood group A antigen pentaose type 1 (>80% NMR) | 5mg | 9911 |
| elicityl-oligotech | GLY100-80% | GT1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 10659 |
| elicityl-oligotech | FUC300 | Fucoidan polysaccharide from Chorda filum | 1000mg | 10004.5 |
| elicityl-oligotech | FUC310 | Fucoidan oligosaccharides (Cut-off < 10kDa) from Chorda filum | 100mg | 10004.5 |
| elicityl-oligotech | FUC400 | Fucoidan polysaccharide from Ascophyllum nodosum | 1000mg | 10004.5 |
| elicityl-oligotech | FUC500 | Fucoidan polysaccharide from Durvillea antarctica | 1000mg | 10004.5 |
| elicityl-oligotech | GLU301-90% | Cellotriose (>90% HPAEC-PAD) | 100mg | 10004.5 |
| elicityl-oligotech | GLU316-99% | Maltohexaose DP6 (>99% HPLC) | 500mg | 10004.5 |
| elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 250mg | 10004.5 |
| elicityl-oligotech | GLU602 | Lichenan & Isolichenan polysaccharide Native grade | 10000mg | 10004.5 |
| elicityl-oligotech | GLU800 | Lentinan polysaccharide | 100mg | 10004.5 |
| elicityl-oligotech | MAN200 | Galactomannan polysaccharides from Guar | 10000mg | 10004.5 |
| elicityl-oligotech | MAN610 | Glucomannan oligosaccharides (cut-off < 10kDA) | 100mg | 10004.5 |
| elicityl-oligotech | ULV010 | Ulvan oligosaccharides (Cut-off < 10kDa) from Ulva sp. | 100mg | 10004.5 |
| elicityl-oligotech | ULV011 | Ulvan oligosaccharides (Cut-off < 10kDa) from Enteromorpha sp. | 100mg | 10004.5 |
| elicityl-oligotech | GLU324-98% | Maltoundecaose DP11 (>98% HPLC) | 25mg | 10098 |
| elicityl-oligotech | XYL110 | Xylan oligosaccharides XOs (Cut-off < 10kDA) from Palmaria p. | 100mg | 10098 |
| elicityl-oligotech | GLY091-GEL | GD3 Ganglioside oligosaccharide grafted on gel matrix - 1 ml | 1mg | 10846 |
| elicityl-oligotech | FRU113-95% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>95% HPAEC-PAD) | 10mg | 10191.5 |
| elicityl-oligotech | GLY031-1-BSA | Blood group H antigen triaose type 1 linked to BSA | 1mg | 10191.5 |
| elicityl-oligotech | GLY031-3-BSA | 2’Fucosyllactose linked to BSA | 1mg | 10191.5 |
| elicityl-oligotech | GLY033-1-BSA | Blood group H antigen pentaose type 1 linked to BSA | 1mg | 10191.5 |
| elicityl-oligotech | FRU113-90% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>90% HPAEC-PAD) | 10mg | 10191.5 |
| elicityl-oligotech | FUC600 | Fucoidan polysaccharide kit. 4 items each in 100 mg pack size | 100mg | 10285 |
| elicityl-oligotech | GAT102 | Galacturonate polysaccharides LM from citrus (sodium salt) | 1000mg | 10285 |
| elicityl-oligotech | REF060 | 3 Fucosyllactose (3-FL) Analytical Reference | 10mg | 10285 |
| elicityl-oligotech | REF089 | 2,6'-Sialyllactose (6'SL) (Sodium salt) Analytical Reference | 10mg | 10285 |
| elicityl-oligotech | GLY095-80% | GT2 Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 11033 |
| elicityl-oligotech | GLY074-2-95% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>95% NMR) | 10mg | 10378.5 |
| elicityl-oligotech | FRU112-95% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>95% HPAEC-PAD) | 10mg | 10472 |
| elicityl-oligotech | GLU327-95% | Maltotridecaose DP13 (>95% HPLC) | 100mg | 10472 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 25mg | 10472 |
| elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 25mg | 10565.5 |
| elicityl-oligotech | GLY074-1-80% | Xeno antigen type 1 (>80% NMR) | 10mg | 10565.5 |
| elicityl-oligotech | GLU302-95% | Cellotetraose (>95% HPAEC-PAD) | 50mg | 10659 |
| elicityl-oligotech | GLU304-80% | Cellohexaose (>80% HPAEC-PAD) | 50mg | 10659 |
| elicityl-oligotech | GLY031-3-85% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>85% NMR) | 100mg | 10659 |
| elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 5mg | 10659 |
| elicityl-oligotech | GLY101-80% | GT1c Ganglioside oligosaccharide (>80% NMR) (Sodium salt) | 5mg | 10659 |
| elicityl-oligotech | FRU114-90% | Fructo-oligosaccharide DP8 / GF7 (>90% HPAEC-PAD) | 10mg | 10846 |
| elicityl-oligotech | GLU306-98% | Cellooctaose (>98% HPAEC-PAD) | 5mg | 10846 |
| elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 250mg | 10846 |
| elicityl-oligotech | GLU324-95% | Maltoundecaose DP11 (>95% HPLC) | 25mg | 10846 |
| elicityl-oligotech | GLU324-99% | Maltoundecaose DP11 (>99% HPLC) | 25mg | 10846 |
| elicityl-oligotech | GLU326-98% | Maltododecaose DP12 (>98% HPLC) | 25mg | 10846 |
| elicityl-oligotech | GLY039-2-90% | Blood group B antigen pentaose type 2 (>90% NMR) | 5mg | 10846 |
| elicityl-oligotech | GLY120-90% | Globotriaose (Gb3) / Pk antigen (>90% HPLC) | 25mg | 10846 |
| elicityl-oligotech | FRU114-95% | Fructo-oligosaccharide DP8 / GF7 (>95% HPAEC-PAD) | 10mg | 10846 |
| elicityl-oligotech | GAT110 | Galacturonan oligosaccharides blocks (OGAs) | 1000mg | 11033 |
| elicityl-oligotech | GLU320-98% | Maltodecaose DP10 (>98% HPLC) | 25mg | 11126.5 |
| elicityl-oligotech | GLY033-1-95% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>95% NMR) | 25mg | 11126.5 |
| elicityl-oligotech | FRU112-70% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>70% HPAEC-PAD) | 50mg | 11220 |
| elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 5mg | 11220 |
| elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 5mg | 11220 |
| elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 10mg | 11313.5 |
| elicityl-oligotech | MAN802 | Mannan polysaccharide from Yeast | 100mg | 11313.5 |
| elicityl-oligotech | REF090 | 3'-Sialyllactose (3'SL) (Sodium salt) Analytical Reference | 10mg | 11313.5 |
| elicityl-oligotech | GLU305-98% | Celloheptaose (>98% HPAEC-PAD) | 10mg | 11407 |
| elicityl-oligotech | GLU301-95% | Cellotriose (>95% HPAEC-PAD) | 100mg | 11500.5 |
| elicityl-oligotech | GLU326-95% | Maltododecaose DP12 (>95% HPLC) | 25mg | 11500.5 |
| elicityl-oligotech | GLU326-99% | Maltododecaose DP12 (>99% HPLC) | 25mg | 11500.5 |
| elicityl-oligotech | GLY251 | Galα1-4Galα1-4Galα1-4Galβ1-4Glc/ Galα1-4Galα1-4Gb3 | 5mg | 11594 |
| elicityl-oligotech | GLY090-90% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 1000mg | 12435.5 |
| elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 5mg | 11687.5 |
| elicityl-oligotech | GLU432-90% | Chitin oligosaccharides DP2 /chitinbiose (>90% RMN) | 50mg | 11781 |
| elicityl-oligotech | GLU433-90% | Chitin oligosaccharides DP3 / chitintriose (>90% RMN) | 50mg | 11781 |
| elicityl-oligotech | GLU314-95% | Maltotetraose DP4 (>95% HPLC) | 500mg | 11874.5 |
| elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 100mg | 11874.5 |
| elicityl-oligotech | GLU1000 | Xyloglucan oligosaccharides | 1000mg | 11968 |
| elicityl-oligotech | GLU328-95% | Maltotetradecaose DP14 (>95% HPLC) | 100mg | 11968 |
| elicityl-oligotech | GLU511 | Curdlan polysaccharide β-(1-3) linked linear glucan prepared by bacterial fermentation | 5000mg | 11968 |
| elicityl-oligotech | GLU601 | Isolichenan polysaccharide | 1000mg | 11968 |
| elicityl-oligotech | GLY120-95% | Globotriaose (Gb3) / Pk antigen (>95% HPLC) | 25mg | 11968 |
| elicityl-oligotech | GAT300 | Rhamnogalacturonan polysaccharide from gombo/okra (sodium salt)) | 100mg | 12061.5 |
| elicityl-oligotech | GLU314-98% | Maltotetraose DP4 (>98% HPLC) | 500mg | 12061.5 |
| elicityl-oligotech | GLY083-70% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>70% NMR) (Sodium salt) | 25mg | 12061.5 |
| elicityl-oligotech | GLY036-1-85% | Blood group A antigen pentaose type 1 (>85% NMR) | 5mg | 12061.5 |
| elicityl-oligotech | GLY099-80% | GD1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY099-90% | GD1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY099-50% | GD1b Ganglioside oligosaccharide (>50%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY100-90% | GT1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY098-90% | GD1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | FRU115-90% | Fructo-oligosaccharide DP9 / GF8 (>90% HPAEC-PAD) | 10mg | 12155 |
| elicityl-oligotech | FRU115-95% | Fructo-oligosaccharide DP9 / GF8 (>95% HPAEC-PAD) | 10mg | 12155 |
| elicityl-oligotech | GLY095-90% | GT2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 5mg | 13090 |
| elicityl-oligotech | GLU314-99% | Maltotetraose DP4 (>99% HPLC) | 500mg | 12248.5 |
| elicityl-oligotech | GLU315-95% | Maltopentaose DP5 (>95% HPLC) | 500mg | 12248.5 |
| elicityl-oligotech | GLY077-90% | Galili antigen heptaose (>90% NMR) | 5mg | 12248.5 |
| elicityl-oligotech | GLY082-85% | Sialylated tetraose type 2 (Sodium salt) (>85% NMR) | 5mg | 12248.5 |
| elicityl-oligotech | LEC302 | BC2LC-Nt from Burkholderia cenocepacia - (Bacterial protein produced in E. coli) | 1mg | 12248.5 |
| elicityl-oligotech | FRU116-95% | Fructo-oligosaccharide DP10 / GF9 (>95% HPAEC-PAD) | 10mg | 12435.5 |
| elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 50mg | 12716 |
| elicityl-oligotech | GLY033-1-98% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>98% NMR) | 25mg | 12716 |
| elicityl-oligotech | GLU317-98% | Maltoheptaose DP7 (>98% HPLC) | 500mg | 12903 |
| elicityl-oligotech | GLU318-95% | Maltooctaose DP8 (>95% HPLC) | 500mg | 12903 |
| elicityl-oligotech | GLU700 | Scleroglucan polysaccharide | 100g | 12903 |
| elicityl-oligotech | GLY009-95% | Lacto-N-Biose (>95% HPLC) | 25mg | 12903 |
| elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 5mg | 12903 |
| elicityl-oligotech | GLY035-3-90% | Blood group A antigen tetraose type 5 (>90% NMR) | 25mg | 12903 |
| elicityl-oligotech | GLY036-1-90% | Blood group A antigen pentaose type 1 (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY036-2-90% | Blood group A antigen pentaose type 2 (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY038-3-90% | Blood group B antigen tetraose type 5 (>90% NMR) | 25mg | 12903 |
| elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY071-90% | Galili antigen pentaose (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY084-2-90% | Sialylated triaose type 2/ 3'-α-sialyl-Acetyl-Lactosamine/ sialyl Lex precursor (>90% NMR) (Sodium salt) | 10mg | 12903 |
| elicityl-oligotech | GLY101-90% | GT1c Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 5mg | 12903 |
| elicityl-oligotech | GLY131-90% | SSEA-4 hexaose / Stage-Specific Embryonic Antigen-4 hexaose (>90% NMR) | 5mg | 12903 |
| elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 25mg | 12903 |
| elicityl-oligotech | GLY160 | Galactosyl-lactose | 25mg | 12903 |
| elicityl-oligotech | GLY161-90% | Difucosylpentaose | 25mg | 12903 |
| elicityl-oligotech | GLY162 | Disialosylpentaose | 25mg | 12903 |
| elicityl-oligotech | GLY171-85% | Sialylated globotriose/ 3Sialyl-Gb3 | 5mg | 12903 |
| elicityl-oligotech | GLY039-1-90% | Blood group B antigen pentaose type 1 (>90% NMR) | 5mg | 12996.5 |
| elicityl-oligotech | GLY180-50% | Glucuronyl-lactose / HNK 1 epitope precursor (Sodium salt) | 25mg | 12996.5 |
| elicityl-oligotech | GLY120-98% | Globotriaose (Gb3) / Pk antigen (>98% HPLC) | 25mg | 13090 |
| elicityl-oligotech | GLY172-85% | Disialylated pentaose type 1 | 5mg | 13090 |
| elicityl-oligotech | MAN801 | Acemannan polysaccharide (Aloe vera) | 100mg | 13090 |
| elicityl-oligotech | GAL100 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Native grade | 10000mg | 13183.5 |
| elicityl-oligotech | GLU327-98% | Maltotridecaose DP13 (>98% HPLC) | 25mg | 13183.5 |
| elicityl-oligotech | GLU327-99% | Maltotridecaose DP13 (>99% HPLC) | 25mg | 13183.5 |
| elicityl-oligotech | GLU328-98% | Maltotetradecaose DP14 (>98% HPLC) | 25mg | 13183.5 |
| elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 50mg | 13183.5 |
| elicityl-oligotech | FRU112-80% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>80% HPAEC-PAD) | 50mg | 13277 |
| elicityl-oligotech | GLU301-98% | Cellotriose (>98% HPAEC-PAD) | 100mg | 13277 |
| elicityl-oligotech | GLY174-90% | GalGalNac-aGM1 (GalGalNAc asialo GM1) Ganglioside oligosaccharide analogue | 5mg | 13277 |
| elicityl-oligotech | ALG601 | Manuronic Block OLS. DP20-DP35 M/G ratio>4 | 100mg | 13370.5 |
| elicityl-oligotech | ALG610 | Guluronate Block OLS. DP25-DP45 | 100mg | 13370.5 |
| elicityl-oligotech | GLY122-85% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>85% NMR) | 25mg | 13370.5 |
| elicityl-oligotech | REF021 | Lacto-N-neotetraose (LNnT / neo-LNT) Analytical Reference | 10mg | 13370.5 |
| elicityl-oligotech | GLY090-95% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>95% NMR) (Sodium salt) | 1000mg | 14305.5 |
| elicityl-oligotech | GLU309-95% | Cello-oligosaccharides Kit 10 mg DP2 to 5 (>95% HPAEC-PAD) and 10 mg DP6 (>80% HPAEC-PAD) | 10mg | 13464 |
| elicityl-oligotech | GLU318-98% | Maltooctaose DP8 (>98% HPLC) | 100mg | 13464 |
| elicityl-oligotech | GLU318-99% | Maltooctaose DP8 (>99% HPLC) | 100mg | 13464 |
| elicityl-oligotech | GLY230-90% | 2’FucosylLactulose / 2’FLactulose | 10mg | 13464 |
| elicityl-oligotech | GLY096-80% | GM1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 25mg | 14586 |
| elicityl-oligotech | GLU315-98% | Maltopentaose DP5 (>98% HPLC) | 500mg | 13651 |
| elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 100mg | 13651 |
| elicityl-oligotech | GAT100 | Galacturonate polysaccharides LM from apple (sodium salt) | 5000mg | 13744.5 |
| elicityl-oligotech | GLY050-90% | Lewis x (LeX) tetraose (>90% NMR) | 25mg | 13744.5 |
| elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 25mg | 13744.5 |
| elicityl-oligotech | GLY121-90% | Globotetraose (Gb4) / P antigen (>90% NMR) | 25mg | 13744.5 |
| elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 1000mg | 13744.5 |
| elicityl-oligotech | FRU117-85% | Fructo-oligosaccharide DP11 / GF10 (>85% HPAEC-PAD) | 10mg | 13931.5 |
| elicityl-oligotech | GLU434-90% | Chitin oligosaccharides DP4 / chitintetraose (>90% RMN) | 50mg | 14025 |
| elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 25mg | 14025 |
| elicityl-oligotech | GLU328-99% | Maltotetradecaose DP14 (>99% HPLC) | 25mg | 14118.5 |
| elicityl-oligotech | GLU328-90% | Maltotetradecaose DP14 (>90% HPLC) | 25mg | 14118.5 |
| elicityl-oligotech | GLY094-95% | GD2 Ganglioside oligosaccharide (>95%) (Sodium salt) | 5mg | 15147 |
| elicityl-oligotech | GLU317-99% | Maltoheptaose DP7 (>99% HPLC) | 500mg | 14212 |
| elicityl-oligotech | GLY022-BSA | Para-Lacto-N-neohexaose linked to BSA | 1mg | 14212 |
| elicityl-oligotech | GLY030-80% | Blood group H antigen disaccharide (>80% NMR) | 100mg | 14212 |
| elicityl-oligotech | GLY030-90% | Blood group H antigen disaccharide (>90% NMR) | 100mg | 14212 |
| elicityl-oligotech | GLY122-BSA | Globopentaose (Gb5) linked to BSA | 1mg | 14212 |
| elicityl-oligotech | GLY123-BSA | Globo-H hexaose (SSEA-3b) linked to BSA | 1mg | 14212 |
| elicityl-oligotech | GLU315-99% | Maltopentaose DP5 (>99% HPLC) | 500mg | 14305.5 |
| elicityl-oligotech | GLU329-95% | Maltopentadecaose DP15 (>95% HPLC) | 25mg | 14305.5 |
| elicityl-oligotech | GLU420 | Chitosan polysaccharide | 100g | 14305.5 |
| elicityl-oligotech | GLU440-2 | Chitin-Oligosaccharides kit from DP 2 to DP 6 | 10mg | 14305.5 |
| elicityl-oligotech | GLY011-BSA | Lacto-N-Triaose (LNT2) linked on BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY021-BSA | Lacto-N-neotetraose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY033-2-BSA | Blood group H antigen pentaose type 2 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY035-3-BSA | Blood group A antigen tetraose type 5 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY037-1-BSA | Blood group A antigen hexaose type 1 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY037-2-BSA | Blood group A antigen hexaose type 2 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY038-3-BSA | Blood group B antigen tetraose type 5 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY040-1-BSA | Blood group B antigen hexaose type 1 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY040-2-BSA | Blood group B antigen hexaose type 2 linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY055-BSA | Lewis a hexaose (LNDFH II) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY064-BSA | α-3Galactosyl-3Fucosyllactose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY067-BSA | 3-Fucosylated Blood group A tetraose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY068-BSA | 3-Fucosylated Blood group B tetraose linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 100mg | 14305.5 |
| elicityl-oligotech | GLY070-BSA | Isoglobotriaose (IsoGb3) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY072-BSA | Isoglobotetraose (Cytolipin R) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY073-BSA | Isoglobopentaose (iGb5) linked to BSA | 1mg | 14305.5 |
| elicityl-oligotech | GLY077-95% | Galili antigen heptaose (>95% NMR) | 5mg | 14305.5 |
| elicityl-oligotech | GLY078-85% | Galili antigen nonaose (>85% NMR) | 5mg | 14305.5 |
| elicityl-oligotech | GLY102-90% | aGM1 (asialo GM1) Ganglioside oligosaccharide / GA1 (>90% NMR) (Sodium salt) | 25mg | 14305.5 |
無錫藥科美生物科技有限公司專業從事生命科學行業前沿技術服務與產品進出口服務，歡迎訂購咨詢全球各國各種進口產品。
歡迎來到
聯系人：賴秀麗
地址：無錫市惠山區惠山大道1699號惠山生命科技園C區5棟5315室
郵箱：46606436@qq.com
傳真：